Fig. 1From: Enrichment Bayesian design for randomized clinical trials using categorical biomarkers and a binary outcomeHIGH Trial: Posterior probabilities of probability of death in both randomized groups, according to patient subsets. In each randomized group in each subset, a Beta-binomial model was used to model the probability of death, where a non-informative Beta(1,1) prior was actualized in a Beta (1+r,1+n− r) posterior distribution based on the observed numbers of deaths r and patients n at the end of the trialBack to article page